Thai Oil Public Company Limited (TOP-R.BK)
THB 35.5
(2.9%)
THB 35.5
(2.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 459.4 Billion | 505.7 Billion | 335.82 Billion | 242.83 Billion | 362.17 Billion | 389.34 Billion |
| Cost of Revenue | 436.16 Billion | 481.13 Billion | 319.55 Billion | 255.3 Billion | 355.75 Billion | 373.12 Billion |
| Gross Profit | 23.23 Billion | 24.56 Billion | 16.27 Billion | -12.46 Billion | 6.42 Billion | 16.21 Billion |
| Operating Expenses | -5.1 Billion | -19.7 Billion | -6.61 Billion | -2.42 Billion | 536.86 Million | 2.78 Billion |
| Selling, General and Administrative Expenses | 3.52 Billion | 4.18 Billion | 3.05 Billion | 2.65 Billion | 2.68 Billion | 2.71 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 1.21 Billion | -23.88 Billion | -9.66 Billion | -5.07 Billion | -2.14 Billion | 338 Million |
| Cost and Expenses | 439.68 Billion | 461.43 Billion | 312.94 Billion | 252.87 Billion | 356.29 Billion | 375.9 Billion |
| Operating Income | 29.55 Billion | 45.88 Billion | 25.18 Billion | -6.37 Billion | 8.76 Billion | 16.24 Billion |
| Interest Expense | 4.08 Billion | 3.86 Billion | 3.59 Billion | 4.29 Billion | 3.3 Billion | 3.84 Billion |
| Income Tax Expense | 4.67 Billion | 8.91 Billion | 2.03 Billion | -646.76 Million | 1.23 Billion | 1.98 Billion |
| Earnings before Tax | 24.25 Billion | 42.02 Billion | 15.09 Billion | -3.24 Billion | 7.75 Billion | 12.36 Billion |
| Net Income | 19.44 Billion | 32.66 Billion | 12.57 Billion | -2.59 Billion | 6.27 Billion | 10.14 Billion |
| Earnings Per Share Basic | 8.70 | 15.96 | 6.17 | -1.27 | 3.07 | 4.98 |
| Earnings Per Share Diluted | 8.70 | 15.96 | 6.17 | -1.27 | 3.07 | 4.96 |
| Weighted Average Shares Outstanding | 2.23 Billion | 2.04 Billion | 2.04 Billion | 2.04 Billion | 2.04 Billion | 2.04 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.23 Billion | 2.04 Billion | 2.04 Billion | 2.04 Billion | 2.04 Billion | 2.04 Billion |
| Gross Margin | 0.05 | 0.05 | 0.05 | -0.05 | 0.02 | 0.04 |
| EBIT Margin | 0.08 | 0.10 | 0.10 | 0.00 | 0.04 | 0.06 |
| Profit Margin | 0.04 | 0.06 | 0.04 | -0.01 | 0.02 | 0.03 |
| EBITDA | 37.35 Billion | 54.14 Billion | 32.6 Billion | 6.03 Billion | 17.04 Billion | 22.38 Billion |
| Earnings Before Tax Margin | 0.06 | 0.09 | 0.07 | -0.03 | 0.02 | 0.04 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 123.51 Billion | 119.53 Billion | 119.55 Billion | 469.24 Billion | 119.65 Billion | 108.46 Billion |
| Cost of Revenue | 116.24 Billion | 109.78 Billion | 116.12 Billion | 436.16 Billion | 104.02 Billion | 105.72 Billion |
| Gross Profit | 7.27 Billion | 9.74 Billion | 3.43 Billion | 33.08 Billion | 15.63 Billion | 2.74 Billion |
| Operating Expenses | 935.39 Million | 840.91 Million | 1.14 Billion | 3.52 Billion | -3.65 Billion | 324.22 Million |
| Selling, General and Administrative Expenses | 935.39 Million | 840.91 Million | 1.14 Billion | - | 899.02 Million | 798.87 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 510.77 Million | 606.22 Million | -465.1 Million | 352 Million | 316.95 Million | 279.35 Million |
| Cost and Expenses | 117.17 Billion | 110.62 Billion | 117.26 Billion | 439.68 Billion | 100.37 Billion | 106.04 Billion |
| Operating Income | 6.34 Billion | 8.9 Billion | 2.28 Billion | 29.55 Billion | 14.59 Billion | 1.69 Billion |
| Interest Expense | 1 Billion | 1.04 Billion | 1.05 Billion | 8.22 Billion | 1.03 Billion | 1.08 Billion |
| Income Tax Expense | 1.15 Billion | 1.46 Billion | 710.27 Million | 4.67 Billion | 2.67 Billion | -523.32 Million |
| Earnings before Tax | 6.76 Billion | 7.48 Billion | 3.65 Billion | 24.17 Billion | 13.56 Billion | 618.35 Million |
| Net Income | 5.54 Billion | 5.86 Billion | 2.94 Billion | 19.44 Billion | 10.82 Billion | 1.11 Billion |
| Earnings Per Share Basic | 2.48 | 2.62 | 1.32 | - | 4.85 | 0.50 |
| Earnings Per Share Diluted | 2.48 | 2.62 | 1.32 | - | 4.85 | 0.50 |
| Weighted Average Shares Outstanding | 2.23 Billion | 2.23 Billion | 2.23 Billion | 2.23 Billion | 2.23 Billion | 2.23 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.23 Billion | 2.23 Billion | 2.23 Billion | 2.23 Billion | 2.23 Billion | 2.23 Billion |
| Gross Margin | 0.06 | 0.08 | 0.03 | 0.07 | 0.13 | 0.03 |
| EBIT Margin | 0.08 | 0.09 | 0.04 | - | 0.18 | 0.04 |
| Profit Margin | 0.04 | 0.05 | 0.02 | 0.04 | 0.09 | 0.01 |
| EBITDA | 9.85 Billion | 10.84 Billion | 4.3 Billion | - | 21.48 Billion | 4.36 Billion |
| Earnings Before Tax Margin | 0.05 | 0.07 | 0.02 | 0.06 | 0.12 | 0.02 |
BALPHARMA
DII-B
PDS
9225
HDYNQ
FSTR